Paragon Medical Sets Up Export Production Base In Changzhou
This article was originally published in PharmAsia News
Paragon Medical, a leading U.S. original equipment manufacturer for the top global medical device suppliers, has selected Changzhou High-tech District as its strategic location to invest in China. As a key export production base for Asia Pacific, the Changzhou facility will mainly manufacture class I orthopedic devices, class I implant components and other metal medical devices. Most of the products will be distributed to the overseas market. (Click here for more - Chinese Language)
You may also be interested in...
The merger between virtual care companies Teladoc and Livongo will offer individuals a wide range of tech-enabled care during a time when telehealth continues to grow.
Regeneron's antibody cocktail for SARS-Cov-2 is largely in holding mode for now, but the company announced progress on other fronts including for Dupixent in COPD and the NGF inhibitor fasinumab.
Market Intel: Why Telehealth, Digital Therapies Will Provide Mental Health Support Beyond COVID-19 Crisis
In this second part of a two-part series focusing on mental health tech, Medtech Insight highlights behavioral digital health companies that have attracted investors’ attention. Part one focused on transcranial magnetic stimulation.